NEW YORK (AP) _ Immunic, Inc. (IMUX) on Thursday reported a loss of $34.5 million in its first quarter.

The New York-based company said it had a loss of $1.63 per share.

The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 69 cents per share.

Immunic shares have fallen 7.5% since the beginning of the year. The stock has climbed 67% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMUX at https://www.zacks.com/ap/IMUX